Cigna Group (NYSE:CI) Announces FY 2026 Earnings Guidance

Cigna Group (NYSE:CI) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 30.450- for the period, compared to the consensus EPS estimate of 30.510. The company issued revenue guidance of $280.0 billion-$280.0 billion, compared to the consensus revenue estimate of $287.2 billion.

Analysts Set New Price Targets

Several research firms have recently weighed in on CI. Evercore initiated coverage on Cigna Group in a report on Wednesday, September 9th. They set an “in-line” rating and a $290.00 price target on the stock. Jefferies Financial Group downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Guggenheim boosted their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 26th. Finally, Barclays lifted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $337.10.

Cigna Group Price Performance

CI opened at $268.41 on Friday. The firm’s fifty day moving average price is $279.18 and its two-hundred day moving average price is $280.56. The company has a market capitalization of $70.92 billion, a price-to-earnings ratio of 11.11, a P/E/G ratio of 0.92 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $71.56 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.Cigna Group’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period last year, the company posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, analysts anticipate that Cigna Group will post 30.45 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th were paid a $1.56 dividend. The ex-dividend date was Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 19,436 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the transaction, the insider owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 22,730 shares of company stock valued at $6,293,359 over the last 90 days. 0.60% of the stock is owned by company insiders.

Key Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna introduced its “Lead to One” strategy, focusing on complex care, specialty pharmacy, clinical expertise, data, technology and artificial intelligence. Management is targeting 10%–14% adjusted EPS compound annual growth through 2030, which supports the long-term investment case. Cigna Investor Day announcement
• Positive Sentiment: The company plans to invest approximately $3 billion in a multiyear modernization, workflow and productivity initiative. Cigna expects the spending to improve operations and support performance over time, although it may weigh on near-term results. Forbes specialty pharmacy investment article
• Positive Sentiment: Royal Bank of Canada reaffirmed its Outperform rating and set a $337 price target, implying substantial upside from the current trading level. Analysts and Seeking Alpha commentary also describe CI as undervalued, citing expected double-digit EPS growth. Cigna valuation analysis
• Neutral Sentiment: Cigna reaffirmed its fiscal 2026 adjusted EPS guidance of approximately $30.45 and continues to pursue international growth, including an arrangement involving UnitedHealthcare. The guidance confirmation reduces uncertainty but did not provide a major upward revision. Cigna international business article
• Negative Sentiment: Fiscal 2026 revenue guidance of $280 billion is below the roughly $287.2 billion analyst consensus, while EPS guidance of $30.45 is slightly under the $30.51 consensus. This near-term shortfall, combined with the cost of the $3 billion initiative, appears to be pressuring the stock despite the stronger long-term outlook. Cigna financial targets article

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.